All posts
-
Novo investors’ confidence under pressure: “There is no room for further disappointments”
Numerous financiers see 2026 as a year for Novo Nordisk to reset and attempt to transform the trend. Yet, lots of continue to be dissatisfied with the firm’s assumptions for …
-
Eli Lilly surpassed Novo Nordisk in key GLP-1 market in 2025
Eli Lilly’s GLP-1 medicines created DKK 231bn in sales in 2014, DKK 3bn greater than Novo Nordisk’s leading medication in the exact same classification.
-
Lundbeck continues acquisition hunt after Avadel defeat
After Lundbeck took out from the fight for Irish firm Avadel in the loss, chief executive officer Charl van Zyl remains to try to find brand-new purchases. However the firm is R…
-
GN notes positive winds in the US after tough year – plans to launch new top product in 2026
In competitors with Demant, GN has actually plainly carried out ideal in 2025, according to experts.
-
11 patients awarded compensation over eye disease linked to Novo products
67 patients have applied for compensation, claiming they developed eye disease as a side effect of Novo Nordisk drugs.
-
Veracode sluit recordjaar af met sterke groei en innovatie te midden van een toenemende vraag naar applicatierisicobeheer
BURLINGTON, Mass.–( ORGANIZATION CABLE)– Veracode, de wereldwijde leider in applicatierisicobeheer, heeft vandaag een jaar van aanzienlijke bedrijfsgroei, productinnova…
-
Veracode conclude un anno da record di crescita e innovazione tra la domanda crescente di gestione del rischio delle applicazioni
BURLINGTON, Mass.–( ORGANIZATION CORD)– Veracode, il leader globale nella gestione del rischio applicativo, oggi ha annunciato un anno di notevole slancio aziendale, in…
-
Veracode clôture une année record en termes de croissance et d'innovation dans un contexte de forte demande en matière de gestion des risques liés aux applications
BURLINGTON, Mass.–( SERVICE CABLE)– Veracode, leader mondial de la gestion des risques liés aux applications, a annoncé aujourd’ hui une année 2025 marquée the sa…
-
Affirm reports second fiscal quarter 2026 results
SAN FRANCISCO–( COMPANY CORD)– Affirm Holdings, Inc. (NASDAQ: AFRM) (” Affirm” or the “Firm”) today reported monetary outcomes for its financial…
